Research Masterclass in Radiotherapy Physics 2017

Potential of BT in prostate cancer

 ASCENDE-RT  Randomised  High and intermediate risk prostate cancer  398 pts  Arm 1: Pelvic 46Gy EBRT + EBRT boost to 78Gy  Arm 2: Pelvic 46Gy EBRT + LDR boost

Intermediate risk

All patients

High risk

Overall survival

Morris et al, IJROBP, 98(2), 275-285, 2017

6